Elena Riboldi

2.2k total citations
31 papers, 1.7k citations indexed

About

Elena Riboldi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Elena Riboldi has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 9 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Elena Riboldi's work include Immunotherapy and Immune Responses (14 papers), Immune Response and Inflammation (10 papers) and Immune cells in cancer (8 papers). Elena Riboldi is often cited by papers focused on Immunotherapy and Immune Responses (14 papers), Immune Response and Inflammation (10 papers) and Immune cells in cancer (8 papers). Elena Riboldi collaborates with scholars based in Italy, United States and Belarus. Elena Riboldi's co-authors include Antonio Sica, Chiara Porta, Silvano Sozzani, Alberto Mantovani, Marco Rusnati, Marco Presta, Valérie Wittamer, David Communi, Marc Parmentier and Jean‐Denis Franssen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

In The Last Decade

Elena Riboldi

30 papers receiving 1.6k citations

Peers

Elena Riboldi
Glen M. Scholz Australia
Wenji Piao United States
Emily Smith United States
Marc Ehlers Germany
Outi Elomaa Finland
Mieke F. Roelofs Netherlands
Adrian Achuthan Australia
Yuanfu Xu China
Glen M. Scholz Australia
Elena Riboldi
Citations per year, relative to Elena Riboldi Elena Riboldi (= 1×) peers Glen M. Scholz

Countries citing papers authored by Elena Riboldi

Since Specialization
Citations

This map shows the geographic impact of Elena Riboldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Riboldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Riboldi more than expected).

Fields of papers citing papers by Elena Riboldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Riboldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Riboldi. The network helps show where Elena Riboldi may publish in the future.

Co-authorship network of co-authors of Elena Riboldi

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Riboldi. A scholar is included among the top collaborators of Elena Riboldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Riboldi. Elena Riboldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porta, Chiara, Antonio Sica, & Elena Riboldi. (2017). Tumor‐associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy. FEBS Journal. 285(4). 717–733. 45 indexed citations
2.
Porta, Chiara, et al.. (2015). Molecular and epigenetic basis of macrophage polarized activation. Seminars in Immunology. 27(4). 237–248. 234 indexed citations
3.
Cardone, Marco, Amiran Dzutsev, Hongchuan Li, et al.. (2014). Interleukin-1 and Interferon-γ Orchestrate β-Glucan-Activated Human Dendritic Cell Programming via IκB-ζ Modulation. PLoS ONE. 9(12). e114516–e114516. 16 indexed citations
4.
Riboldi, Elena, Chiara Porta, Sara Morlacchi, et al.. (2012). Hypoxia-mediated regulation of macrophage functions in pathophysiology. International Immunology. 25(2). 67–75. 75 indexed citations
5.
Riboldi, Elena, Roberta Daniele, Antonio Inforzato, et al.. (2011). Human C-type Lectin Domain Family 4, Member C (CLEC4C/BDCA-2/CD303) Is a Receptor for Asialo-galactosyl-oligosaccharides. Journal of Biological Chemistry. 286(41). 35329–35333. 36 indexed citations
6.
Naldini, Antonella, et al.. (2011). Hypoxia affects dendritic cell survival: Role of the hypoxia‐inducible factor‐1α and lipopolysaccharide. Journal of Cellular Physiology. 227(2). 587–595. 65 indexed citations
7.
Sica, Antonio, Chiara Porta, Sara Morlacchi, et al.. (2011). Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs). Cancer Microenvironment. 5(2). 133–149. 77 indexed citations
8.
Porta, Chiara, Elena Riboldi, & Antonio Sica. (2010). Mechanisms linking pathogens-associated inflammation and cancer. Cancer Letters. 305(2). 250–262. 91 indexed citations
9.
Lyakh, Lyudmila, Marco Cardone, Elena Riboldi, & Giorgio Trinchieri. (2009). Regulation of IL-1beta and IL-23 production by beta-glucan in human dendritic cells (135.76). The Journal of Immunology. 182(Supplement_1). 135.76–135.76. 1 indexed citations
10.
Bosisio, Daniela, Marisa Vulcano, Annalisa Del Prete, et al.. (2008). Blocking TH17-polarizing cytokines by histone deacetylase inhibitors in vitro and in vivo. Journal of Leukocyte Biology. 84(6). 1540–1548. 57 indexed citations
11.
Sozzani, Silvano, Marco Rusnati, Elena Riboldi, Stefania Mitola, & Marco Presta. (2007). Dendritic cell–endothelial cell cross-talk in angiogenesis. Trends in Immunology. 28(9). 385–392. 106 indexed citations
12.
Alaibac, Mauro, Emilio Berti, Carlo Chizzolini, et al.. (2006). Role of cellular immunity in the pathogenesis of autoimmune skin diseases. Experimental Dermatology. 24. 3 indexed citations
13.
Alaibac, Mauro, Emilio Berti, Carlo Chizzolini, et al.. (2006). Role of cellular immunity in the pathogenesis of autoimmune skin diseases.. PubMed. 24(1 Suppl 40). S14–9. 22 indexed citations
14.
Vermi, William, Elena Riboldi, Valérie Wittamer, et al.. (2005). Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. The Journal of Experimental Medicine. 201(4). 509–515. 243 indexed citations
15.
Migeotte, Isabelle, Elena Riboldi, Jean‐Denis Franssen, et al.. (2004). Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. The Journal of Experimental Medicine. 201(1). 83–93. 106 indexed citations
16.
Vulcano, Marisa, Stefano Dusi, Daniele Lissandrini, et al.. (2004). Toll Receptor-Mediated Regulation of NADPH Oxidase in Human Dendritic Cells. The Journal of Immunology. 173(9). 5749–5756. 109 indexed citations
17.
Riboldi, Elena, Giada Frascaroli, Pietro Transidico, et al.. (2003). Benzydamine inhibits monocyte migration and MAPK activation induced by chemotactic agonists. British Journal of Pharmacology. 140(2). 377–383. 23 indexed citations
18.
Locati, Massimo, Elena Riboldi, Raffaella Bonecchi, et al.. (2001). Selective induction of phospholipase D1 in pathogen-activated human monocytes. Biochemical Journal. 358(1). 119–119. 18 indexed citations
19.
Locati, Massimo, Elena Riboldi, Raffaella Bonecchi, et al.. (2001). Selective induction of phospholipase D1 in pathogen-activated human monocytes. Biochemical Journal. 358(1). 119–125. 13 indexed citations
20.
Riboldi, Elena & Rodolfo Saracci. (1991). Diet, hormones and cancer: methodological issues for prospective studies. Analytica Chimica Acta. 242. 303–303. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026